Table 1.
Reasons for suspicion of preeclampsia and assessing the sFlt-1/PlGF ratio (full analysis population n = 192).
Fig 1.
Patient populations in the PreOS study for (A) mothers and (B) neonates.
Table 2.
PreOS patient demographics and baseline characteristics.
Table 3.
Analysis of decisions after sFlt-1/PlGF ratio measurement (per-protocol population, n = 118).
Fig 2.
(A) Primary endpoint decisions on hospitalization changes based on the sFlt-1/PlGF result (per-protocol population, n = 118) and (B) summary of all endpoint decisions before and after knowledge of the sFlt-1/PlGF ratio (all changes were considered appropriate by the adjudicators) (per-protocol population, n = 118).
Table 4.
Intended procedures before and after knowledge of the sFlt-1/PlGF ratio and selected outcomes for mothers/neonates (per-protocol population, n = 118).